DNA THERAPEUTICS
Corporate overview > Investors
 
Investors  print this page
 

June 2008, an investor syndicate led by Inserm-Transfert Initiative, together with G1J-Ile de France, Blue Medical Investments and a group of international business angels, was committed to invest 800,000 EUR based on certain milestones to be met, in a seed financing round with combined equity and bond investment.

January 2009, an investor syndicate led by SGAM SEFTI with two the previous seed investors, Blue Medical Investments & G1J-Ile de France, was committed ton invest 2,200,000 EUR based on certain milestones to be met, in a series A equity investment financing round.




top of page